12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Regulus Therapeutics RGLS stock rose 7.6% to $0.22 during Thursday's pre-market session. The market value of their outstanding shares is at $32.2 million.
  • PAVmed PAVM stock moved upwards by 7.08% to $1.36. The market value of their outstanding shares is at $119.7 million.
  • Selecta Biosciences SELB shares rose 6.5% to $0.81. The company's market cap stands at $122.6 million.
  • First Wave BioPharma FWBI shares moved upwards by 6.31% to $0.69. The market value of their outstanding shares is at $11.5 million.
  • AlloVir ALVR shares increased by 6.02% to $4.75. The market value of their outstanding shares is at $310.4 million.
  • Trevena TRVN stock moved upwards by 5.81% to $0.32. The market value of their outstanding shares is at $52.9 million.

Losers

  • Teladoc Health TDOC stock fell 43.1% to $31.86 during Thursday's pre-market session. The market value of their outstanding shares is at $5.1 billion. The company's, Q1 earnings came out yesterday.
  • Sio Gene Therapies SIOX shares fell 36.99% to $0.38. The market value of their outstanding shares is at $28.0 million.
  • Align Tech ALGN stock declined by 22.6% to $279.0. The company's market cap stands at $21.9 billion. As per the press release, Q1 earnings came out yesterday.
  • Cosmos Holdings COSM shares fell 21.84% to $1.11. The company's market cap stands at $19.4 million.
  • Ocuphire Pharma OCUP shares decreased by 18.46% to $1.9. The company's market cap stands at $36.0 million.
  • Xenetic Biosciences XBIO shares fell 15.09% to $0.72. The market value of their outstanding shares is at $9.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!